A cell-permeable caveolin-1 peptide has been demonstrated to antagonize monocrotaline-induced PAH (Jasmin et al. 2006), suggesting pathogenic similarities between heritable and acquired forms of the disease. The gene discussed is CAV1; the disease is pulmonary arterial hypertension.